Institute of Hematology & Blood Diseases Hospital

Spliceosome gene mutations synergize with anthracyclines to amplify atrial fibrillation risk in hematologic malignancies: a multicenter cohort study with discovery and validation

Abstract Background Atrial fibrillation (AF) is a life‑threatening complication in patients with hematologic malignancies, yet personalized risk stratification remains challenging. Spliceosome gene mutations are key drivers of these malignancies, but their specific role in AF pat...

Occurrence of FLT3 mutations in acute myeloid leukemia and comparison of different methodologies

Fms-like tyrosine kinase 3 (FLT3) mutations occur in approximately 30% of adult patients with acute myeloid leukemia (AML) and are clinically significant for prognosis and targeted therapy. Detection early is essential for treatment decisions. This study evaluated the performance...

Top2a complexes with Trim28 to orchestrate stemness of embryonic stem cells and tumorigenesis

Type II topoisomerase α (Top2a) is crucial for maintaining the stemness of embryonic stem cells (ESCs) and is upregulated in various human cancers, yet the mechanisms underlying its cell type-specific functions remain elusive. Here, using an unbiased proteomic approach, we discov...